Processing your payment...
Please do not close your browser.

Biopharmaceuticals Contract Manufacturing Service Market- Global Growth, Trends and Forecast (2022 - 2028) By Product Type (Peptides/Proteins, Antibodies, Vaccines, Biosimilars, and Other Product Types) and By Regions

28 Jun, 2022 | 132 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Over the forecast period the Biopharmaceuticals Contract Manufacturing Service Market will register a CAGR 7.5 % in term of revenue and the global Market size will reach USD in xx Billion by 2028.

Biopharmaceuticals Contract Manufacturing Service Market Overview

Increased outsourcing volume by biopharmaceutical companies, increased investments in research and development, and growth of services given by contract manufacturing organisations (CMOs) are all important driving drivers for the biopharmaceutical contract manufacturing market. To satisfy their fill-and-finish demands and avoid risk, most biotechnology businesses continue to outsource to contract manufacturing organisations (CMOs). Because they lack in-house manufacturing capability, several small biotechnology businesses outsource their production needs, avoiding capital expenditures and lowering business risk. Because they lack the essential knowledge to build long-term manufacturing processes, these companies are considered key CMO customers.

Contract service providers' rise has been facilitated by breakthrough technical inventions and discoveries in bioprocessing, which have helped them overcome industrial problems such as high production costs and the need for batch changeover. The need for biopharmaceutical contract manufacturing services is driven by a number of reasons.

What is our Biopharmaceuticals Contract Manufacturing Service Market report scope?

 

Report Attributes

 

 

Report Details

 

Forecast Period 2022 to 2028

 

CAGR of 7.5 % during the review period (2022 to 2028).

 

By Product Type

  • Peptides/Proteins
  • Antibodies
  • Vaccines
  • Biosimilars
  • and Other Product Types

 

 

 

 

By Companies

  • Boehringer Ingelheim GmbH
  • JRS Pharma (Celonic)
  • Lonza Group
  • Rentschler Biotechnologie GmbH
  • Inno Biologics Sdn Bhd
  • Others

 

 

Regions Covered

 

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

 

 

 

 

 

 

 

Countries Covered

  • US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America

Forecast Year

 

2022 to 2028

Number of Pages

132

 

Customization Available

 

 

Yes, the report can be customized as per your needs

Who are the Major Players in Biopharmaceuticals Contract Manufacturing Service Market?

Market Growth Reports lists out all the Biopharmaceuticals Contract Manufacturing Service Market companies that are presently striving to reduce the impact of the Covid-19 pandemic on the Market- Boehringer Ingelheim GmbH, JRS Pharma (Celonic), Lonza Group, Rentschler Biotechnologies GmbH, Inno Biologics Sdn Bhd, Others

Industry News:

Lonza and Junshi Biosciences Collaborate to Accelerate the Development and Manufacturing of Biologics

"The signing of this collaboration indicates that the relationship between the two parties has been taken to a new level. As a major milestone for Lonza's biopharmaceutical facility in Guangzhou, the collaboration also demonstrates Lonza's vision to provide high-quality and reliable services for local pharmaceutical companies under the CDMO model. We look forward to providing comprehensive services and professional support for Junshi Biosciences, helping to accelerate the process of drug development, production and commercialization."

What are the major Product Types for Biopharmaceuticals Contract Manufacturing Service Market?

By Product Type, it is segmented into

  • Peptides/Proteins
  • Antibodies
  • Vaccines
  • Biosimilars

and Other Product Types

Biopharmaceuticals Contract Manufacturing Service Market Regional Analysis

Furthermore, increased research & development spending is a crucial driver driving the market growth. JSR, for example, formed a corporate venture fund focused on small and developing biotech in March 2021, attracting consumers to its life sciences services portfolio. CARE (Corona Accelerated R&D in Europe), a new initiative backed by the Innovative Medications Initiative (IMI) public-private partnership, was established in August 2020 to speed up the research and development of critically required medicines to treat SARS-CoV-2, the virus that causes COVID-19.

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Middle East & Africa
    • Latin America
  1. INTRODUCTION
    • MARKET DEFINITION
    • MARKET DYNAMICS
    • MARKET SEGMENTATION
    • REPORT TIMELINES
    • KEY STAKEHOLDERS
  2. RESEARCH METHODOLOGY
    • DATA MINING
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
      • SUBJECT MATTER EXPERT ADVICE
    • QUALITY CHECK
    • FINAL REVIEW
      • DATA TRIANGULATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
      • RESEARCH FLOW
  3. EXECUTIVE SUMMARY
    • INTRODUCTION
    • GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING SERVICE MARKET BY PRODUCT TYPES
  4. MARKET DYNAMICS
    • DRIVERS
      • INCREASING GERIATRIC POPULATION AND PREVALENCE OF CHRONIC DISEASE
    • RESTRAINTS
      • STRINGENT ENVIRONMENTAL REGULATIONS
      • HIGH COST OF MATERIALS
    • OPPORTUNITIES
      • BIOPHARMACEUTICALS CONTRACT MANUFACTURING SERVICE GROWTH
    • APPLICATION OF BIOPHARMACEUTICALS CONTRACT MANUFACTURING SERVICE IMPACT OF COVID 19
  5. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING SERVICE MARKET, BY PRODUCT TYPES
    • INTRODUCTION
    • PEPTIDES/PROTEINS
    • ANTIBODIES
    • VACCINES
    • BIOSIMILARS
    • AND OTHER PRODUCT TYPES
  6. GLOBAL BIOPHARMACEUTICALS CONTRACT MANUFACTURING SERVICE MARKET, BY REGION
    • NORTH AMERICA
      • US
      • CANADA
      • MEXICO
    • EUROPE
      • GERMANY
      • FRANCE
      • UK
      • ITALY
      • RUSSIA
      • REST OF EUROPE
    • APAC
      • CHINA
      • SOUTH KOREA
      • JAPAN
      • INDIA
      • AUSTRALIA
      • ASEAN
      • REST OF APAC
    • MIDDLE EAST AND AFRICA
      • SAUDI ARABIA
      • UAE
      • SOUTH AFRICA
      • TURKEY
      • REST OF MEA
    • SOUTH AMERICA
      • BRAZIL
      • REST OF MEA
      • ARGENTINA
      • REST OF SOUTH AMERICA
  7. COMPETITIVE LANDSCAPE
    • MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,
    • AND AGREEMENTS
      • KEY DEVELOPMENT
    • MARKET SHARE PERCENT/RANKING ANALYSIS
    • STRATEGIES ADOPTED BY LEADING PLAYERS
  8. COMPANY PROFILES
    • BUSINESS OVERVIEW
    • COMPANY SNAPSHOT
    • PRODUCT BENCHMARKING
    • STRATEGIC INITIATIVES
  1. BOEHRINGER INGELHEIM GMBH
  2. JRS PHARMA (CELONIC)
  3. LONZA GROUP
  4. RENTSCHLER BIOTECHNOLOGIE GMBH
  5. INNO BIOLOGICS SDN BHD
  6. OTHERS

 

 

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Request A Sample

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Korean Institute of Tuberculosis
  • Sanyo chemical Industries LTD
  • Novartis
  • Hisamitsu
  • Pfizer
  • AbbVie
  • RevHealth
  • Zeon Corporation
  • Abbott (Established Pharmaceutical Products)
  • Sinopharm (pharmaceutical distribution segment)
  • Takeda Pharmaceutical
  • Gilead Sciences
  • Sartorius
  • Zavation
  • Permobil
  • Ansell
  • Cefla